BioSpace News Archive

METTLER TOLEDO is pleased to announce the launch of its brand-new, fully certified InMotion KF Oven Autosamplers: InMotion Flex and InMotion Pro.

Concept Life Sciences (Concept), the integrated drug discovery, development and analytical services company, today announced it has appointed Philip Payne as Chief Commercial Officer, to support the group’s continued growth.

BONE THERAPEUTICS today announces that it will participate in the following upcoming key investor and partnering conferences in the fourth quarter of 2017: Bio-Europe.

Magenta Therapeutics today announced the addition of Jeff Albers, Blake Byers and Alison Lawton to its Board of Directors.

Transcat today reported financial results for its second quarter ended September 23, 2017 of fiscal year 2018, which ends March 31, 2018.

Curetis N.V. today announced it has started collecting patient samples for a multi center FDA study for its Unyvero IJI Cartridge for the detection of invasive joint infections.

Tandem Diabetes Care, Inc. announced that it will make any new features approved for the t:slim X2 Insulin Pump by the FDA in 2018 available to all in-warranty users at no cost through the Tandem Device Updater.

Shimadzu Scientific Instruments (SSI) announces the release of its new IRSpirit Fourier Transform Infrared (FTIR) Spectrophotometer. The smallest and lightest FTIR instrument from Shimadzu, the IRSpirit provides unmatched functionality in its class of compact instruments and offers exceptional reliability in contaminat analysis identification tests and quantitative measurements.

Biohaven and its wholly owned subsidiary, Biohaven Pharma, today announced that the FDA has notified the Company that it may proceed with its clinical investigation of trigriluzole, a novel glutamate modulator, as a potential treatment for patients with OCD.

Novasep today announced a EUR4M investment to expand cGMP capacity for clinical and commercial supply of APIs at its Chasse-sur-Rhone facility.